ECOLAB INC.

ECL 10-K · Q4 2025

ECL Q4 2025 request

Playground key active
Request URL /api/financials?ticker=ECL&year=2025&quarter=4
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q4 2025 Q4 2024 YoY
Revenue 4,196 4,005.2 +4.8%
Show Product Lines breakouts
Product and equipment sales 3,297.2 3,158 +4.4%
Product and equipment sales · Global Institutional and Specialty 1,257 1,207.5 +4.1%
Product and equipment sales · Global Life Sciences 197.3 177.3 +11.3%
Product and equipment sales · Global Water 1,842.9 1,773.2 +3.9%
Service and lease sales 898.8 847.2 +6.1%
Service and lease sales · Global Institutional and Specialty 291.1 281.2 +3.5%
Service and lease sales · Global Life Sciences 10 10.9 -8.3%
Service and lease sales · Global Pest Elimination 316.5 293.8 +7.7%
Service and lease sales · Global Water 281.2 261.3 +7.6%
Show Business Segments breakouts
Global Institutional and Specialty 1,548.1 1,488.7 +4.0%
Global Institutional and Specialty · Asia Pacific 91.2 83.5 +9.2%
Global Institutional and Specialty · CA 62.8 61.6 +1.9%
Global Institutional and Specialty · CN 50.2 46.5 +8.0%
Global Institutional and Specialty · Europe 269.9 259.1 +4.2%
Global Institutional and Specialty · India, Middle East and Africa 28.6 29.7 -3.7%
Global Institutional and Specialty · Latin America 55.2 50.6 +9.1%
Global Institutional and Specialty · Operating Segments 1,499 1,458.7 +2.8%
Global Institutional and Specialty · US 990.2 957.7 +3.4%
Global Life Sciences 207.3 188.2 +10.1%
Global Life Sciences · Asia Pacific 20.1 11.1 +81.1%
Global Life Sciences · CA 0.9 0.7 +28.6%
Global Life Sciences · CN 15 16.3 -8.0%
Global Life Sciences · Europe 110 97.2 +13.2%
Global Life Sciences · India, Middle East and Africa 8 10.6 -24.5%
Global Life Sciences · Latin America 4.6 6.3 -27.0%
Global Life Sciences · Operating Segments 191.4 179.7 +6.5%
Global Life Sciences · US 48.7 46 +5.9%
Global Pest Elimination 316.5 293.8 +7.7%
Global Pest Elimination · Asia Pacific 9.5 8.5 +11.8%
Global Pest Elimination · CA 3.4 3.1 +9.7%
Global Pest Elimination · CN 15.8 15.1 +4.6%
Global Pest Elimination · Europe 55.8 50.9 +9.6%
Global Pest Elimination · India, Middle East and Africa 1.8 1.9 -5.3%
Global Pest Elimination · Latin America 16.1 14.4 +11.8%
Global Pest Elimination · Operating Segments 307.2 287.9 +6.7%
Global Pest Elimination · US 214.1 199.9 +7.1%
Global Water 2,124.1 2,034.5 +4.4%
Global Water · Asia Pacific 256.8 252 +1.9%
Global Water · CA 61.4 57.5 +6.8%
Global Water · CN 102.8 99 +3.8%
Global Water · Europe 458.6 418.6 +9.6%
Global Water · India, Middle East and Africa 150.3 143 +5.1%
Global Water · Latin America 231.9 207.6 +11.7%
Global Water · Operating Segments 2,017.4 1,967.6 +2.5%
Global Water · US 862.3 856.8 +0.6%
Show Consolidation Items breakouts
Material Reconciling Items 181 111.3 +62.6%
Operating Segments 4,015 3,893.9 +3.1%
Cost of Revenue 2,348.4 2,269.1 +3.5%
Show Product Lines breakouts
Product and equipment sales 1,832.9 1,769 +3.6%
Service and lease sales 515.5 500.1 +3.1%
Show Business Segments breakouts
Corporate · Operating Segments 0.1 2 -95.0%
Global Institutional and Specialty · Operating Segments 764.9 758.5 +0.8%
Global Life Sciences · Operating Segments 105.8 107 -1.1%
Global Pest Elimination · Operating Segments 169.5 164 +3.4%
Global Water · Operating Segments 1,205.2 1,173.3 +2.7%
Show — breakouts
Cost of Revenue -0.6 0.3 -300.0%
Show Consolidation Items breakouts
Operating Segments 2,245.5 2,204.8 +1.8%
Selling, General & Administrative 1,061 1,050 +1.0%
Show Business Segments breakouts
Corporate · Operating Segments 49.3 48.4 +1.9%
Global Institutional and Specialty · Operating Segments 399.3 412.5 -3.2%
Global Life Sciences · Operating Segments 53 41.1 +29.0%
Global Pest Elimination · Operating Segments 75.3 81.2 -7.3%
Global Water · Operating Segments 450.6 444.1 +1.5%
Show — breakouts
Selling, General & Administrative -0.6 2.1 -128.6%
Show Consolidation Items breakouts
Operating Segments 1,027.5 1,027.3 0.0%
Other Nonrecurring Income Expense 74.6 103.3 -27.8%
Show Product Lines breakouts
Product and equipment, and service and lease · Cost Of Sales 0.1 2.1 -95.2%
Show Business Segments breakouts
Corporate · Operating Segments 72.6 103.4 -29.8%
Show Consolidation Items breakouts
Operating Segments 72.6 103.4 -29.8%
Show Income Statement Location breakouts
Cost Of Sales 0.1 2.1 -95.2%
Special (gains) and charges 74.6 103.3 -27.8%
Operating Income 712 582.8 +22.2%
Show Business Segments breakouts
Corporate · Operating Segments -122 -153.8 +20.7%
Global Institutional and Specialty · Operating Segments 334.8 287.7 +16.4%
Global Life Sciences · Operating Segments 32.6 31.6 +3.2%
Global Pest Elimination · Operating Segments 62.4 42.7 +46.1%
Global Water · Operating Segments 361.6 350.2 +3.3%
Show Consolidation Items breakouts
Material Reconciling Items 42.6 24.4 +74.6%
Operating Segments 669.4 558.4 +19.9%
Non-Operating Income (Expense) -12.6 -13.2 +4.5%
Interest Expense Net 64.3 61.7 +4.2%
Show — breakouts
Interest Expense Net -0.2 -0.5 +60.0%
Income Before Taxes 660.3 534.3 +23.6%
Income Tax Expense (Benefit) 91.7 54.8 +67.3%
Net Income 568.6 479.5 +18.6%
Show Equity Components breakouts
Noncontrolling Interest 4.7 6.6 -28.8%
Parent 563.9 472.9 +19.2%
Retained Earnings 563.9 472.9 +19.2%
Net Income Loss Attributable To Noncontrolling Interest 4.7 6.6 -28.8%
Net Income 563.9 472.9 +19.2%
EPS (Basic) 2 1.67 +19.8%
EPS (Diluted) 1.98 1.65 +20.0%
Wtd Avg Shares (Basic) -0.2 -0.3 +33.3%
Wtd Avg Shares (Diluted) -0.1 -0.2 +50.0%
Interest Income -18.6 -17.5 -6.3%
Comprehensive Income 593.5 344.7 +72.2%
Professional Fees (Q)
Show Disposal Group Classification breakouts
Disposal Group Disposed Of By Sale Not Discontinued Operations · Global surgical solutions business 0.6 1 -40.0%
Show Income Statement Location breakouts
Special (gains) and charges · One Ecolab Initiative Program 6.3 7.5 -16.0%
Interest Expense 82.9 79.2 +4.7%
Operating Lease Lease Income 146 136.6 +6.9%

Balance Sheet

Balance Sheet
Metric Q4 2025 Q4 2024 YoY
Current Assets
Cash & Cash Equivalents 646.2 1,256.8 -48.6%
Accounts Receivable 3,249.4 2,865 +13.4%
Inventory 1,490.4 1,464.9 +1.7%
Other Assets Current 569.6 439 +29.7%
Total Current Assets 5,955.6 6,025.7 -1.2%
Non-Current Assets
Property, Plant & Equipment 4,276.6 3,752.4 +14.0%
Goodwill 9,227 7,907.3 +16.7%
Show Business Segments breakouts
Global Institutional and Specialty 1,041.5 1,024.3 +1.7%
Global Life Sciences 2,490.4 2,408.7 +3.4%
Global Pest Elimination 189.6 169.4 +11.9%
Global Water 5,505.5 4,304.9 +27.9%
Show Business Acquisition breakouts
Series Of Individually Immaterial Business Acquisitions 17.4 156.7 -88.9%
Operating Lease Right-of-Use Assets 765.9 723.2 +5.9%
Other Non-Current Assets 782.7 670.4 +16.8%
Total Assets 24,696.3 22,387.8 +10.3%
Intangible Assets 2,458.5 2,078.8 +18.3%
Deferred Tax Assets 181 155.5 +16.4%
Other Assets
Intangible Assets Net Excluding Goodwill 3,688.5 3,308.8 +11.5%
Current Liabilities
Debt Current 870.4 615.7 +41.4%
Accounts Payable 2,071 1,810 +14.4%
Employee Related Liabilities Current 721.5 727.4 -0.8%
Accrued Income Taxes Current 134.3 127 +5.7%
Other Liabilities Current 1,737.5 1,512.7 +14.9%
Total Current Liabilities 5,534.7 4,792.8 +15.5%
Commercial Paper (Q)
Show Debt Instrument breakouts
U.S. commercial paper program 100
Non-Current Liabilities
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent 546.1 634.9 -14.0%
Show Retirement Plan Type breakouts
Defined Benefit Postretirement Health Coverage · US 90.7 91.5 -0.9%
Pension Plans Defined Benefit · Foreign Plan 383.7 370.5 +3.6%
Pension Plans Defined Benefit · US 66.9 142.8 -53.2%
Deferred Tax Liabilities 329.9 280 +17.8%
Other Non-Current Liabilities 518.7 366.2 +41.6%
Total Liabilities 14,891.8 13,598.6 +9.5%
Other Liabilities
Long Term Debt And Capital Lease Obligations 7,365.9 6,949.2 +6.0%
Operating Lease Liability Noncurrent Excluded From Long Term Debt 596.5 575.5 +3.6%
Stockholders' Equity
Common Stock 369.4 367.8 +0.4%
Additional Paid In Capital Common Stock 7,521.3 7,159.6 +5.1%
Retained Earnings 12,834 11,517.1 +11.4%
Accumulated Other Comprehensive Income -1,874.3 -1,982 +5.4%
Treasury Stock Value -9,079.6 -8,305.2 -9.3%
Total Stockholders' Equity 9,770.8 8,757.3 +11.6%
Minority Interest 33.7 31.9 +5.6%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 9,804.5 8,789.2 +11.6%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -1,874.3 -1,982 +5.4%
Additional Paid In Capital 7,521.3 7,159.6 +5.1%
Common Stock 369.4 367.8 +0.4%
Noncontrolling Interest 33.7 31.9 +5.6%
Parent 9,770.8 8,757.3 +11.6%
Retained Earnings 12,834 11,517.1 +11.4%
Treasury Stock Common -9,079.6 -8,305.2 -9.3%
Total Liabilities & Equity 24,696.3 22,387.8 +10.3%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q4 2025 YTD Q4 2024 YoY
Operating Activities
Depreciation 178.8 161.2 +10.9%
Adjustment For Amortization 77.3 74.3 +4.0%
Deferred Income Taxes And Tax Credits 23.7 -40.8 +158.1%
Stock-Based Compensation 27.1 25.3 +7.1%
Pension And Other Postretirement Benefit Contributions -10.7 -10.7 -0.0%
Pension And Other Postretirement Benefit Expense 4.6 2.8 +64.3%
Restructuring Costs 31.3 35.4 -11.6%
Gain Loss On Sale Of Business 0 1 -100.0%
Other Non-Cash Items 8.4 6.6 +27.3%
Change in Accounts Receivable -35.6 -37.4 +4.8%
Change in Inventory 74 48 +54.2%
Increase Decrease In Other Operating Assets 49.5 16.8 +194.6%
Change in Accounts Payable 115.5 22.3 +417.9%
Increase Decrease In Other Operating Liabilities -22.4 -17.6 -27.3%
Net Cash from Operations 1,090.1 766.7 +42.2%
Investing Activities
Capital Expenditures -332.1 -359.7 +7.7%
Proceeds From Sale Of Productive Assets 5.9 8 -26.3%
Payments To Acquire Businesses And Interest In Affiliates -1,620.8 -256.5 -531.9%
Proceeds From Divestiture Of Businesses Net Of Cash Divested 0 0
Other Investing Activities -31.2 -19.3 -61.7%
Net Cash from Investing -1,978.2 -627.5 -215.3%
Financing Activities
Proceeds From Repayments Of Short Term Debt 97.1 -1.4 +7035.7%
Repayments Of Long Term Debt 0 0
Share Repurchases -409.2 -2.8 -14514.3%
Payments Of Dividends Common Stock -189.2 -161.4 -17.2%
Proceeds From Stock Options Exercised 46.2 26.6 +73.7%
Proceeds From Payments For Other Financing Activities -3.1 -1.1 -181.8%
Net Cash from Financing -431.6 -140.1 -208.1%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 10.1 -3.4 +397.1%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations -1,309.6 -4.3 -30355.8%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 646.2 1,256.8 -48.6%

Values in millions USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key